The spread of the Aedes aegypti mosquito, which transmits the Zika virus as well as dengue, Rift Valley fever, and ...

The world’s first vaccine for mosquito-borne chikungunya virus has been approved by the UK’s Medicines and Healthcare ...

Zika virus is currently present in over 90 countries and spreading at a rapid pace, thanks to Aedes aegypti mosquitoes, which ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...

Chikungunya virus (CHIKV) is a mosquito-borne virus that has gained significant attention due to its widespread outbreaks and the severe health impacts it can cause. The disease, known as ...

Zika virus hijacks the skin of its human host to send out chemical signals that lure more mosquitoes to infect and spread the ...

Despite the constant presence of mosquitoes, the risk of disease transmission fluctuates throughout the year between high and low risk months.

Valneva has recieved Medicines and Healthcare products Regulatory Agency (MHRA) authorisation in the UK for the world’s first ...

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq: Saint Herblain, France Thursday, February 6, 2025, 12:00 Hrs [IST] Valneva SE, a specialty vacci ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...